Immunotherapy for advanced or metastatic urothelial carcinoma

Philipp Maisch, Eu Chang Hwang, Vikram Narayan, Caitlin J. Bakker, Frank Kunath, Philipp Dahm

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.

Original languageEnglish (US)
Article numberCD013774
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number11
DOIs
StatePublished - Nov 2 2020

Bibliographical note

Funding Information:
Philipp Maisch received salary support as a Cochrane Urology Fellow through the Deutsche Forschungs GemeinschaC (DFG)

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Fingerprint

Dive into the research topics of 'Immunotherapy for advanced or metastatic urothelial carcinoma'. Together they form a unique fingerprint.

Cite this